Putting the antibiotics chloramphenicol and linezolid into context.

Crowe-McAuliffe, Caillan; Wilson, Daniel N

Crowe-McAuliffe, Caillan; Wilson, Daniel N.

Affiliation

Crowe-McAuliffe C; Institute for Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany.
Wilson DN; Institute for Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany. daniel.wilson@chemie.uni-hamburg.de.

Nat Struct Mol Biol ; 29(2): 79-81, 2022 02.

Article in En | MEDLINE | ID: mdl-35165457

Subject(s)

Anti-Bacterial Agents/chemistry; Anti-Bacterial Agents/pharmacology; Chloramphenicol/chemistry; Chloramphenicol/pharmacology; Linezolid/chemistry; Linezolid/pharmacology; Bacteria/drug effects; Bacteria/genetics; Bacteria/metabolism; Drug Development; Drug Resistance, Bacterial/genetics; Humans; Models, Molecular; Oxazolidinones/chemistry; Oxazolidinones/pharmacology; Protein Biosynthesis/drug effects; Protein Synthesis Inhibitors/chemistry; Protein Synthesis Inhibitors/pharmacology; Ribosomes/drug effects; Ribosomes/metabolism; Structure-Activity Relationship

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chloramphenicol / Linezolid / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Struct Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google